TU
TMO icon

TDAM USA’s Thermo Fisher Scientific TMO Stock Holding History

TDAM USA’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$1.9M Sell
2,849
-14,659
-84% -$9.15M 0.12% 124
2021
Q3 		$10M Sell
17,508
-207
-1% -$114K 0.66% 45
2021
Q2 		$9.57M Sell
17,715
-1,349
-7% -$636K 0.59% 50
2021
Q1 		$8.7M Sell
19,064
-1,293
-6% -$617K 0.53% 61
2020
Q4 		$9.48M Sell
20,357
-1,446
-7% -$678K 0.59% 49
2020
Q3 		$9.63M Buy
21,803
+95
+0.4% +$39.2K 0.66% 43
2020
Q2 		$7.62M Buy
21,708
+17,924
+474% +$6.01M 0.55% 56
2020
Q1 		$1.07M Sell
3,784
-970
-20% -$306K 0.09% 153
2019
Q4 		$1.54M Sell
4,754
-572
-11% -$173K 0.1% 152
2019
Q3 		$1.55M Sell
5,326
-82
-2% -$23.5K 0.11% 150
2019
Q2 		$1.59M Sell
5,408
-538
-9% -$148K 0.11% 146
2019
Q1 		$1.63M Buy
5,946
+141
+2% +$35.1K 0.12% 133
2018
Q4 		$1.3M Sell
5,805
-519
-8% -$122K 0.09% 151
2018
Q3 		$1.45M Sell
6,324
-132
-2% -$30.4K 0.09% 167
2018
Q2 		$1.34M Buy
6,456
+197
+3% +$41.8K 0.08% 173
2018
Q1 		$1.29M Buy
6,259
+264
+4% +$55.4K 0.08% 171
2017
Q4 		$1.14M Sell
5,995
-190
-3% -$36.4K 0.07% 192
2017
Q3 		$1.17M Sell
6,185
-972
-14% -$176K 0.07% 184
2017
Q2 		$1.25M Buy
7,157
+385
+6% +$64.7K 0.06% 186
2017
Q1 		$1.04M Sell
6,772
-473
-7% -$72.3K 0.05% 205
2016
Q4 		$1.02M Sell
7,245
-375
-5% -$55.3K 0.05% 210
2016
Q3 		$1.21M Sell
7,620
-1,136
-13% -$175K 0.06% 202
2016
Q2 		$1.29M Buy
8,756
+1,134
+15% +$167K 0.06% 188
2016
Q1 		$1.08M Buy
7,622
+5,903
+343% +$791K 0.05% 218
2015
Q4 		$244K Sell
1,719
-482
-22% -$64.3K 0.01% 333
2015
Q3 		$269K Buy
+2,201
New +$287K 0.01% 325
2014
Q4 		– Sell
-2,291
Closed -$279K – 344
2014
Q3 		$279K Sell
2,291
-39
-2% -$4.74K 0.01% 279
2014
Q2 		$275K Sell
2,330
-1,171
-33% -$138K 0.01% 281
2014
Q1 		$421K Sell
3,501
-33,426
-91% -$3.97M 0.02% 253
2013
Q4 		$4.11M Buy
+36,927
New +$3.67M 0.18% 126

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TDAM USA's TMO Position: Q4 2021 in Review

TDAM USA reduced its Thermo Fisher Scientific (TMO) stake by 84% in Q4 2021, selling an estimated $9.15M and leaving 2,849 shares worth $1.9M. The position accounts for 0.12% of the portfolio, ranked #124.

TDAM USA first reported a position in TMO in Q4 2013 and has held it in 30 quarters since. The position peaked at $10M in Q3 2021. 2,343 funds tracked by Wall St. Rank hold TMO as of Q4 2021.

  • TDAM USA held 2,849 shares of Thermo Fisher Scientific worth $1.9M as of Q4 2021.
  • TDAM USA sold 14,659 Thermo Fisher Scientific shares in Q4 2021, an estimated $9.15M.
  • Thermo Fisher Scientific made up 0.12% of TDAM USA's portfolio in Q4 2021, its #124 holding.
  • TDAM USA first reported a position in Thermo Fisher Scientific in Q4 2013 and has held it in 30 quarters since.
  • TDAM USA's Thermo Fisher Scientific position peaked at $10M in Q3 2021.
  • 2,343 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2021.

Based on TDAM USA's 13F filing for Q4 2021, filed 10 Feb 2022.